1. From the Division of Experimental Critical Care Medicine, Department of Research (R.R.M., N.M., S.S., U.E.), Medicine A, Department of Internal Medicine (L.H., U.E.), and Institute of Pathology (S.D., S.S.), University Hospital, Basel, Switzerland; Department of Host Defence (S.A.), Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; and IMBA (J.M.P.), Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.